share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Desmond-Hellmann Susan

SEC announcement ·  Apr 26 13:24
Summary by Moomoo AI
Susan Desmond-Hellmann, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As such, the impact of this event on Desmond-Hellmann's holdings and on Pfizer's stock is currently unclear.
Susan Desmond-Hellmann, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As such, the impact of this event on Desmond-Hellmann's holdings and on Pfizer's stock is currently unclear.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more